Search

Your search keyword '"Dell'Aquila E"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Dell'Aquila E" Remove constraint Author: "Dell'Aquila E"
211 results on '"Dell'Aquila E"'

Search Results

51. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO.

53. Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib

55. A20 - Rechallenge with cetuximab (cet) + irinotecan (iri) in 3rd-line in RAS and BRAF wt metastatic colorectal cancer (mCRC) patients (pts) with acquired resistance to 1st-line cet + iri: the phase II CRICKET study by GONO

56. Fractional Branes in Landau-Ginzburg Orbifolds

57. Folfoxiri Plus Bevacizumab (Bev) As First-Line Treatment of Ras Wild-Type (Wt) Metastatic Colorectal Cancer (Mcrc) Patients (Pts)

59. D05 - FOLFOXIRI plus bevacizumab (bev) as upfront treatment for metastatic colorectal cancer (mCRC) patients (pts) with initially unresectable liver-limited disease (LLD)

60. Chiral observables and S-duality in $$ \mathcal{N} $$ = 2 U( N ) gauge theories.

66. 91 EMBRYO DEVELOPMENT AFTER ICSI OF EQUINE OOCYTES VITRIFIED BEFORE AND AFTER IVM

68. Teachers’ multicultural personality traits as predictors of intercultural conflict management styles: Evidence from five European countries

69. Hyper-Activity Books and Serious Games: How to Promote Experiential Learning beyond Distance

70. 'Don’t Get Distracted!': The Role of Social Robots’ Interaction Style on Users’ Cognitive Performance, Acceptance, and Non-Compliant Behavior

71. Coding and educational robotics with peers: The C0D1NC experience to foster inclusion

72. Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer

73. Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter 'SLAVE' Study

74. What Would You Like to Drink?

75. A Preparatory Study for Measuring Engagement in Pediatric Virtual and Robotics Rehabilitation Settings

76. Cheating with a socially assistive robot? a matter of personality

77. Creating Digital Environments for Interethnic Conflict Management

78. The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference

79. An approach to evaluating the user experience of serious games

80. Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer

81. Attain Cultural Integration through teachers' Conflict Resolution skills Development: The ACCORD project

82. Evaluating the Emotional Valence of Affective Sounds for Child-Robot Interaction

83. Pharmacogenomics of cetuximab in metastatic colorectal carcinoma

84. Situated Psychological Agents: A Methodology for Educational Games

85. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

86. P-101 - A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy.

87. O-013 - Impact of age and gender on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: a pooled analysis of TRIBE and TRIBE2 studies.

88. Microwave-ultrasound simultaneous irradiation: a hybrid technology applied to ring closing metathesis

89. Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: A multicentric retrospective analysis

90. Synthesis of novel multi-cationic PEG-based ionic liquids

91. Poly(ethylene glycol)-based ionic liquids: properties and uses as alternative solvents in organic synthesis and catalysis

92. Sponde impervie e rive fiorite. Sinisgalli tra scienze e letteratura

93. Dicer and drosha expression and response to bevacizumab-based therapy in advanced colorectal cancer patients

95. The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors

96. Editorial: Future frontiers in the management of metastatic colorectal cancer.

97. Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.

98. Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis.

99. Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.

100. Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis.

Catalog

Books, media, physical & digital resources